Moderna (MRNA) has had the highest return since June 15, 2026 by a US stock with a market cap of $5B+, returning 340.5%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 340.53% |
Iovance Biotherapeutics (IOVA) | 244.9% |
10X Genomics (TXG) | 145.88% |
Kodiak Sciences (KOD) | 132.42% |
PBF Energy (PBF) | 129.31% |
Atlassian (TEAM) | 127.4% |
GRAIL, LLC (GRAL) | 121.82% |
NIQ Global Intelligence (NIQ) | 118.56% |
CVR Energy (CVI) | 113.46% |
Netskope, Inc Class A Common Stock (NTSK) | 110.99% |
Ringcentral (RNG) | 92.82% |
Marathon Petroleum (MPC) | 91.62% |
HF Sinclair (DINO) | 90.31% |
Gitlab (GTLB) | 88.78% |
Everpure (P) | 88.65% |
Valero Energy (VLO) | 88.62% |
Twist Bioscience (TWST) | 86.72% |
Natera (NTRA) | 84.77% |
Veeva Systems Inc Class A (VEEV) | 83.31% |
Xp (XP) | 82.25% |
Okta (OKTA) | 81.12% |
Paycom Software (PAYC) | 78.82% |
Calumet Specialty Products Partners (CLMT) | 72.81% |
Bending Spoons SpA (BSP) | 72.45% |
Phillips 66 (PSX) | 72.17% |